Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



Bristol-Myers Squibb issues voluntary recall of Eliquis lot

Pharmaceutical firm Bristol-Myers Squibb has announced a voluntary recall of one lot of Eliquis (apixaban) 5mg tablets following a consumer complaint that their bottle contained 2.5mg tablets. The affected lot is a 60-count bottle containing 5mg tablets of the medication and it was distributed...

Read More

Endo reviews FDA request to remove Opana ER from market

Endo International is reviewing a request from the US Food & Drug Administration (FDA) to remove the opioid pain medication Opana ER (oxymorphone hydrochloride extended release) from the market. The government body's Drug Safety Risk Management and Anesthetic and Analgesic Drug Products...

Read More

How to Dispose of Expired or Out-of-Date Medication

Look through the drawers and cupboards of most households in the United States it's likely you'll find a blister pack or pill bottle with out-of-date or expired medication tucked away somewhere. So what should you do with these medicines? Are they safe to use, and how should you dispose of them if...

Read More

Cheaper generic Strattera approved for ADHD treatment

The US Food & Drug Administration (FDA) has approved a generic form of Eli Lilly and Company's Strattera (atomoxetine), used to treat patients with attention-deficit/hyperactivity disorder (ADHD). The generic non-stimulant ADHD medication will be brought to market by Apotex Inc., Teva...

Read More

COPD patients with Medicare Part D 'struggle with inhaler costs'

Many patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...

Read More

New cetirizine eye drops good news for allergy sufferers

A topical ocular cetirizine formulation has gained US Food & Drug Administration (FDA) New Drug Application approval for treating allergic conjunctivitis. Zerviate (cetirizine ophthalmic solution 0.24%) was developed by ophthalmic research and development company Nicox. The new topical...

Read More

Contraceptive pill batch recalled by Lupin Pharmaceuticals

Lupin Pharmaceuticals has announced the voluntary recall of a batch of Mibelas 24 Fe (norethindrone acetate and ethinylestradiol) 1mg/0.02mg chewable tablets and ferrous fumarate 75 mg) tablets. The medication is a oral contraceptive and taking the tablets in an incorrect order may place users at...

Read More

How to manage and control grass allergy symptoms

Late spring and early summer are the toughest times of the year for many patients suffering from grass allergies and hay fever. Grasses and plants release grains of pollen to fertilize other plants, but many people struggle with allergic reactions to these pollens. These cause uncomfortable...

Read More

Cancer medication based on biomarker "an important first"

The US Food & Drug Administration's (FDA) decision to approve a medication to treat patients whose cancer has a specific genetic feature, or biomarker, has been hailed as an "important first" in the fight against the disease. Keytruda (pembrolizumab) is a monoclonal antibody already in use to...

Read More

Sanofi's Kevzara approved as rheumatoid arthritis treatment

Sanofi and Regeneron Pharmaceuticals have gained approval from the US Food & Drug Administration (FDA) for use of Kevzara (sarilumab) for treating patients with rheumatoid arthritis. The prescription medication will be available to patients who do not respond to, or are intolerant, to disease...

Read More

5 Ways to Reduce the Cost of Prescription Medication

Over the last 12 months, one-quarter of Americans have experienced an increase in the cost of their prescription medication, according to Consumer Reports. The organization's Best Buy Drugs Prescription Costs and Concerns nationally representative survey found six out of ten patients with rising...

Read More

New generic hypertension medication available in pharmacies

Patients with hypertension now have a cheaper medication option following the US Food & Drug Administration's approval of generic olmesartan medoxomil and hydrochlorothiazide tablets.  Aurobindo Pharma USA's latest addition to pharmacies across the country was previously only available as...

Read More

Obesity 'raises risk of osteoarthritis in the hands'

Osteoarthritis of the hands is likely to affect up to four in ten people during their lifetime and obesity may increase the risk of developing the condition, a new study has found. Osteoarthritis is the most common form of arthritis, affecting more than 30 million people across the...

Read More

FDA approves Radicava: The first new ALS drug in 22 years

The US Food & Drug Administration (FDA) has approved the first new treatment for patients with amyotrophic lateral sclerosis (ALS) in 22 years. FDA approval for Radicava (edaravone) was granted following a six-month trial in Japan in which patients given the drug exhibited a slower rate of...

Read More

Teva's generic Vytorin brings cheaper statin to US patients

A generic version of the cholesterol-lowering medication Vytorin has been launched by Teva Pharmaceutical Industries, bringing another cheaper statin medication to US pharmacies. Vytorin is an HMG-COA reductase inhibitor/statin with a lipid modifying agent developed by Merck.  IMS data from...

Read More